Essential BioTech (EBT) is a biotechnology company found by Dr James Ooi eight years ago in Singapore. The company’s vis
Posted: Sat Feb 19, 2022 3:06 pm
Essential BioTech (EBT) is a biotechnology company found by Dr
James Ooi eight years ago in Singapore. The company’s vision is to
enhance people’s well-being through life science discoveries and it
specialises in developing pharmaceutical products.
James aspires EBT to be another Genentech, a famous American
biotechnology firm. James has built up EBT through recruiting
dedicated staff and collaborating with the industry partners and
research institutions. It has a research laboratory and a
small-scale manufacturing facility in Science Park. Recently, there
has been an increasing number of projects and production
demands.
Assuming that it is December 2021. There is a virus codenamed
Covid-Pi spreading across the world that is highly contagious and
causes high mortality rates. This gives EBT’s management an impetus
to develop a vaccine quickly to counter the Covid-Pi virus. The
project is named the Covid Destroyer Vaccine (CDV) Project.
The national sovereign wealth fund, Tembusu Pte Ltd (TPL), wants
to invest in EBT and help provide funds to develop the vaccine. TPL
demands to know the CDV Project’s periodic progress. Munich Bio
Life Ag (MBL) from Germany is a new ingredient supplier to EBT. It
will work with EBT to formulate a specific protein as the base
ingredient for the new vaccine.
The CEO has assembled the following staff to form the CDV
Project Team:
1. You, an EBT Product Manager, are appointed as the CDV Project
Manager and the vaccine’s Business Manager after it is launched.
Besides general project management, you are also responsible for
its publicity.
2. Dr. Sharifah, an EBT biotechnologist. She will analyse the
Covid-Pi virus to develop the vaccine with the help of MBL. She
will also conduct clinical trials and seek World Health
Organisation’s approval.
3. Mr Bala, an EBT Production Manager. He will set up the new
vaccine production line.
4. Mr. Genz, a chemist from MBL. He will support the project
from Germany on the formulation of a protein designed by Dr.
Sharifah.
Section 1: Leading the Project and Managing the Project Team
Question 1
(b) From your perspective, differentiate four (4) major external
organisations or groups of people (i.e., outside of EBT and as an
organisation or a group, and not a single person) as stakeholders
in this project. For each stakeholder, define its role in the CDV
Project or the eventual vaccine business, and describe this
stakeholder’s dependency on the CDV Project or the vaccine
business. Propose a currency and explain how you will use it to
influence this stakeholder.
Note: (i) You may state your assumptions.
(ii) You must not repeat the same currency for different
stakeholders.
James Ooi eight years ago in Singapore. The company’s vision is to
enhance people’s well-being through life science discoveries and it
specialises in developing pharmaceutical products.
James aspires EBT to be another Genentech, a famous American
biotechnology firm. James has built up EBT through recruiting
dedicated staff and collaborating with the industry partners and
research institutions. It has a research laboratory and a
small-scale manufacturing facility in Science Park. Recently, there
has been an increasing number of projects and production
demands.
Assuming that it is December 2021. There is a virus codenamed
Covid-Pi spreading across the world that is highly contagious and
causes high mortality rates. This gives EBT’s management an impetus
to develop a vaccine quickly to counter the Covid-Pi virus. The
project is named the Covid Destroyer Vaccine (CDV) Project.
The national sovereign wealth fund, Tembusu Pte Ltd (TPL), wants
to invest in EBT and help provide funds to develop the vaccine. TPL
demands to know the CDV Project’s periodic progress. Munich Bio
Life Ag (MBL) from Germany is a new ingredient supplier to EBT. It
will work with EBT to formulate a specific protein as the base
ingredient for the new vaccine.
The CEO has assembled the following staff to form the CDV
Project Team:
1. You, an EBT Product Manager, are appointed as the CDV Project
Manager and the vaccine’s Business Manager after it is launched.
Besides general project management, you are also responsible for
its publicity.
2. Dr. Sharifah, an EBT biotechnologist. She will analyse the
Covid-Pi virus to develop the vaccine with the help of MBL. She
will also conduct clinical trials and seek World Health
Organisation’s approval.
3. Mr Bala, an EBT Production Manager. He will set up the new
vaccine production line.
4. Mr. Genz, a chemist from MBL. He will support the project
from Germany on the formulation of a protein designed by Dr.
Sharifah.
Section 1: Leading the Project and Managing the Project Team
Question 1
(b) From your perspective, differentiate four (4) major external
organisations or groups of people (i.e., outside of EBT and as an
organisation or a group, and not a single person) as stakeholders
in this project. For each stakeholder, define its role in the CDV
Project or the eventual vaccine business, and describe this
stakeholder’s dependency on the CDV Project or the vaccine
business. Propose a currency and explain how you will use it to
influence this stakeholder.
Note: (i) You may state your assumptions.
(ii) You must not repeat the same currency for different
stakeholders.